|
1
|
de Groen PC, Gores GJ, LaRusso NF,
Gunderson LL and Nagorney DM: Biliary tract cancers. N Engl J Med.
341:1368–1378. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tyson GL, Ilyas JA, Duan Z, Green LK,
Younes M, El-Serag HB and Davila JA: Secular trends in the
incidence of cholangiocarcinoma in the USA and the impact of
misclassification. Dig Dis Sci. 59:3103–3110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Landis SH, Murray T, Bolden S and Wingo
PA: Cancer statistics, 1998. CA Cancer J Clin. 48:6–29. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patel T: Worldwide trends in mortality
from biliary tract malignancies. BMC Cancer. 2:102002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khan SA, Davidson BR, Goldin R, Pereira
SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC,
Thursz MR and Wasan H: British Society of Gastroenterology:
Guidelines for the diagnosis and treatment of cholangiocarcinoma:
Consensus document. Gut. 51(Suppl 6): VI1–VI9. 2002. View Article : Google Scholar
|
|
6
|
Zhang TC, Cao EH, Li JF, Ma W and Qin JF:
Induction of apoptosis and inhibition of human gastric cancer
MGC-803 cell growth by arsenic trioxide. Eur J Cancer.
35:1258–1263. 1999. View Article : Google Scholar
|
|
7
|
Shaib Y and El-Serag HB: The epidemiology
of cholangiocarcinoma. Semin Liver Dis. 24:115–125. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu GT: Pharmacological actions and
clinical use of fructus schizandrae. Chin Med J. 102:740–749.
1989.PubMed/NCBI
|
|
9
|
Li L, Wang T, Xu ZL, Yu Y, Chen W and Chen
F: Effects of schisandrin B on reversing multidrug resistance in
human breast cancer cells transfected with mdr1 gene. Zhonghua Yi
Xue Za Zhi. 85:1633–1637. 2005.In Chinese. PubMed/NCBI
|
|
10
|
Liu XN, Zhang CY, Jin XD, Li YZ, Zheng XZ
and Li L: Inhibitory effect of schisandrin B on gastric cancer
cells in vitro. World J Gastroenterol. 13:6506–6511. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu YF, Cao MF, Gao YP, Chen F, Wang T,
Zumbika EP and Qian KX: Down-modulation of heat shock protein 70
and up-modulation of caspase-3 during schisandrin B-induced
apoptosis in human hepatoma SMMC-7721 cells. World J Gastroenterol.
10:2944–2948. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Q, Lu XH, Wang CD, Cai L, Lu JL, Wu JS,
Zhuge QC, Zheng WM and Su ZP: Antiproliferative and
apoptosis-inducing activity of schisandrin B against human glioma
cells. Cancer Cell Int. 15:122015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Z, Zhang B, Liu K, Ding Z and Hu X:
Schisandrin B attenuates cancer invasion and metastasis via
inhibiting epithelial-mesenchymal transition. PLoS One.
7:e404802012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishida H, Tatewaki N, Nakajima Y, Magara
T, Ko KM, Hamamori Y and Konishi T: Inhibition of ATR protein
kinase activity by schisandrin B in DNA damage response. Nucleic
Acids Res. 37:5678–5689. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu YP, Tan ZJ, Wu XS, Liu TY, Jiang L, Bao
RF, Shu YJ, Li ML, Weng H, Ding Q, et al: Triptolide induces s
phase arrest and apoptosis in gallbladder cancer cells. Molecules.
19:2612–2628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bloom J and Cross FR: Multiple levels of
cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol.
8:149–160. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nigg EA: Cyclin-dependent protein kinases:
Key regulators of the eukaryotic cell cycle. BioEssays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harbour JW, Luo RX, Dei Santi A, Postigo
AA and Dean DC: Cdk phosphorylation triggers sequential
intramolecular interactions that progressively block Rb functions
as cells move through G1. Cell. 98:859–869. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ezhevsky SA, Ho A, Becker-Hapak M, Davis
PK and Dowdy SF: Differential regulation of retinoblastoma tumor
suppressor protein by G1 cyclin-dependent kinase
complexes in vivo. Mol Cell Biol. 21:4773–4784. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hinds PW, Mittnacht S, Dulic V, Arnold A,
Reed SI and Weinberg RA: Regulation of retinoblastoma protein
functions by ectopic expression of human cyclins. Cell.
70:993–1006. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chinkwo KA: Sutherlandia frutescens
extracts can induce apoptosis in cultured carcinoma cells. J
Ethnopharmacol. 98:163–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Asgar MA, Senawong G, Sripa B and Senawong
T: Synergistic anticancer effects of cisplatin and histone
deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell
lines. Int J Oncol. 48:409–420. 2016.
|
|
24
|
Hu W and Kavanagh JJ: Anticancer therapy
targeting the apoptotic pathway. Lancet Oncol. 4:721–729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reed JC: Apoptosis-regulating proteins as
targets for drug discovery. Trends Mol Med. 7:314–319. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng L, Zheng J, Wu LJ and Zhao YY:
Julibroside J8-induced HeLa cell apoptosis through caspase pathway.
J Asian Nat Prod Res. 8:457–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Antonsson B: Mitochondria and the Bcl-2
family proteins in apoptosis signaling pathways. Mol Cell Biochem.
256–257:141–155. 2004. View Article : Google Scholar
|
|
28
|
Pal S, Pal PB, Das J and Sil PC:
Involvement of both intrinsic and extrinsic pathways in
hepatoprotection of arjunolic acid against cadmium induced acute
damage in vitro. Toxicology. 283:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsujimoto Y: Bcl-2 family of proteins:
Life-or-death switch in mitochondria. Biosci Rep. 22:47–58. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Das A, Banik NL, Patel SJ and Ray SK:
Dexamethasone protected human glioblastoma U87MG cells from
temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and
preventing proteolytic activities. Mol Cancer. 3:362004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang YH, Wu YL, Tashiro S, Onodera S and
Ikejima T: Reactive oxygen species contribute to oridonin-induced
apoptosis and autophagy in human cervical carcinoma HeLa cells.
Acta Pharmacol Sin. 32:1266–1275. 2011. View Article : Google Scholar : PubMed/NCBI
|
